Cargando…
Cannabinoid Effect and Safety in Spasticity Following Stroke: A Double-Blind Randomized Placebo-Controlled Study
BACKGROUND: Nabiximols is a cannabis-based drug to treat spasticity-associated symptoms currently approved for patients with multiple sclerosis only. Cannabinoids are useful in an increasing number of medical conditions but may bear an increased risk for cardiovascular events. SativexStroke is a dou...
Autores principales: | Marinelli, Lucio, Puce, Luca, Mori, Laura, Leandri, Massimo, Rosa, Gian Marco, Currà, Antonio, Fattapposta, Francesco, Trompetto, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261779/ https://www.ncbi.nlm.nih.gov/pubmed/35812088 http://dx.doi.org/10.3389/fneur.2022.892165 |
Ejemplares similares
-
A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity
por: Marinelli, Lucio, et al.
Publicado: (2017) -
Spasticity, spastic dystonia, and static stretch reflex in hypertonic muscles of patients with multiple sclerosis
por: Puce, Luca, et al.
Publicado: (2021) -
Nabiximols effect on blood pressure and heart rate in post-stroke patients of a randomized controlled study
por: Rosa, Gian Marco, et al.
Publicado: (2022) -
Shear wave elastography combined with electromyography to assess the effect of botulinum toxin on spastic dystonia following stroke: A pilot study
por: Campanella, William, et al.
Publicado: (2022) -
Effectiveness of Botulinum Toxin on Pain in Stroke Patients Suffering from Upper Limb Spastic Dystonia
por: Trompetto, Carlo, et al.
Publicado: (2022)